DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement
The purpose of this study is to learn about discussion between clinicians and their patients related to lung screening. Survey answers will be collected from both clinicians and their patients.
Checked against the public recordLast updated Aug 23, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Hackensack Meridian Health
- Interventions being studied
- Behavioral: Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale); Behavioral: Patient Trust in the Medical; Behavioral: Decision Conflict Scale (DCS) - Lung Cancer Screening; Behavioral: Shared Decision Making Questionnaire (SDM-Q)- Patient; Behavioral: Stage of Readiness for Smoking Cessation - Contemplation Ladder; Behavioral: Primary Care Clinicians' Lung Cancer Screening Survey
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: CLINICIANS: * Clinician (physician, nurse practitioner, or physician assistant) * Practicing in a KPWA primary care clinic * Having a patient panel with \>/= 10 lung cancer screening eligible patients PATIENTS (Quantitative Phase): * Age 55-80 years * \>/= 30 pack-year tobacco smoking history * Current smoker or former smoker who has quit within the past 15 years * Documented SDM lung cancer screening discussion during a recent clinic visit Exclusion Criteria: PATIENTS: * Significant comorbidities (Charlson Comorbidity Index \>/=3) * Lung cancer diagnosis
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Kaiser Permanente Washington Health Research InstituteSeattle, Washington
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 23, 2024. Always confirm current availability with the study team.